LEXICON PHARMACEUTICALS INC (LXRX) Stock Cash Flow
USA - NASDAQ:LXRX - US5288723027 - Common Stock
1.37 USD
-0.02 (-1.44%)
1.41 USD
+0.04 (+2.92%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -120.62M | -200.40M | -177.12M | -101.90M | -87.80M | |||
| Depreciation Amortization | 603.00K | 534.00K | 554.00K | 400.00K | 300.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | 0.00 | |||
| Change In Working Capital | 13.42M | 14.24M | 2.66M | 400.00K | -10.20M | |||
| Interest Paid | 11.29M | 12.92M | 10.06M | 2.30M | 800.00K | |||
| Other non cash items | 4.70M | 6.85M | 12.01M | 12.30M | 10.70M | |||
| OPERATING CASH FLOW | -101.89M | -178.78M | -161.90M | -88.90M | -87.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -1.03M | -470.00K | -1.30M | -1.20M | |||
| Other Investing Activity | 164.01M | -14.35M | -49.47M | -69.80M | 3.30M | |||
| INVESTING CASH FLOW | 163.23M | -15.38M | -49.94M | -71.10M | 2.10M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 49.96M | 48.90M | -11.70M | |||
| Stock Issued/Repurchased | -685.00K | 239.66M | 138.00M | 93.30M | 34.40M | |||
| Other Financing Activity | -907.00K | -1.31M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -46.59M | 238.35M | 187.96M | 142.20M | 22.70M | |||
| CHANGE IN CASH | 14.75M | 44.19M | -23.88M | -17.80M | -62.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -101.89M | -178.78M | -161.90M | -88.90M | -87.00M | |||
| Capital Expenditure | N/A | -1.03M | -470.00K | -1.30M | -1.20M | |||
| FREE CASH FLOW | -102.68M | -179.81M | -162.37M | -90.20M | -88.20M | |||
All data in USD